The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain

@article{Jaggar1998TheAA,
  title={The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain},
  author={Si{\^a}n Isobel Jaggar and Fauzia Hasnie and Senthy V. Sellaturay and Andrew S. C. Rice},
  journal={Pain},
  year={1998},
  volume={76},
  pages={189-199}
}

Figures from this paper

The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain.
TLDR
Cannabinoids are highly potent and efficacious antihyperalgesic agents in a model of neuropathic pain and are likely to be mediated via an action in the CNS and in the periphery.
Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat
TLDR
The antiinflammatory effect of nabilone is shown and that of palmitoylethanolamide is confirmed indicating that these actions are mediated by an uncharacterized CB2‐like cannabinoid receptor.
A Novel Neuroimmune Mechanism in Cannabinoid-mediated Attenuation of Nerve Growth Factor–induced Hyperalgesia
TLDR
Cannabinoids show a neuronal CB1 receptor–mediated antihyperalgesic action and a separate inhibition of a proinflammatory neuroimmune process, which suggests a therapeutic site of analgesic action separable from central side effects.
...
...

References

SHOWING 1-10 OF 90 REFERENCES
Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat
TLDR
It is demonstrated that AEA in the unanaesthetized rat exerts behavioural and physiological effects generally similar to those seen following natural cannabinoids and synthetic cannabimimetic agents and suggests a role for AEE in regulation of various physiological processes.
The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.
TLDR
It is demonstrated that anandamide produces effects in a tetrad of tests used to predict cannabimimetic activity and supports the contention of its role as an endogenous cannabinoid ligand.
Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice.
  • S. Welch, D. Stevens
  • Biology, Medicine
    The Journal of pharmacology and experimental therapeutics
  • 1992
TLDR
Although pretreatment with morphine somewhat enhanced the effects of delta 9-THC, pretreatment of the mice with naloxone failed to block the antinociceptive effects of the cannabinoids, indicating that the cannabinoid-induced ant inociception does not occur due to direct interaction with the opiate receptor.
The dose‐related effects of paracetamol on hyperalgesia and nociception in the rat
TLDR
The results suggest that paracetamol can reduce hyperalgesia without affecting physiological nociception and inflammation.
Spinal and supraspinal components of cannabinoid-induced antinociception.
  • A. Lichtman, B. Martin
  • Biology, Psychology
    The Journal of pharmacology and experimental therapeutics
  • 1991
The purpose of this study was to investigate whether cannabinoids produce antinociception spinal and supraspinal sites of action. The antinociceptive effect of delta 9-tetrahydrocannabinol (3 or 10
Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.
TLDR
The observations suggest that several selective opioid agonists can modulate responses to noxious pressure through a peripheral opioid receptor-specific site of action in inflammation and that these receptors possess distinguishable pharmacological characteristics resembling those of mu, delta and kappa receptors.
...
...